Responses
Case Report
Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
Compose a Response to This Article
Other responses
No responses have been published for this article.
